Der er ikke foretaget forligelighedsundersøgelser med andre intravenøse substanser, additiver eller lægemidler end 9 mg/ ml (0, 9%) natriumchloridinfusionsvæske eller 50 mg/ ml (5%) glucoseinfusionsvæske.
The compatibility of reconstituted ECALTA with intravenous substances, additives, or medicines other than 9 mg/ ml (0.9%) sodium chloride for infusion or 50 mg/ ml (5%) glucose for infusion has not been established.